- IBDoc® Patient Support
An interview with Prof. Dr. Patrick van Rheenen University Medical Center Groningen, The Netherlands Can you introduce yourself and your organization? My name is Patrick van Rheenen and I work
Collecting a faecal sample at home can seem a daunting process. This demonstration using the CALEX® Device outlines the best practice for collection, based on your sample type and what
Ailsa Ralph, NHS Trainee Clinical Scientist With the onset of COVID one of the big challenges faced by many hospitals was having sufficient access to biosafety cabinets for sample handling,
Kezia Allen, Associate Practitioner – Clinical Trials, Basildon Hospital The demands on healthcare resources continue to escalate, with the COVID pandemic having exacerbated the existing pressures from an aging population
The IBDoc® test kit is outlined in this video. The kit allows for faecal calprotectin testing in the privacy of your own home, provides results in a timely fashion and
Switching to the new fPELA turbo assay for improved workflow and efficiency Kaleem Fayyaz, Blood Sciences Team Leader, Spire Manchester Hospital Spire Healthcare is a leading UK independent hospital group.
From the Siemens Advia 2400 to the Atellica Analyser Georgette Glover, Senior Biomedical Scientist, Biochemistry Department, Addenbrookes Hospital Addenbrookes Hospital has been using the BÜHLMANN calprotectin assays for a number
IBDoc Calprotectin Home Test from BÜHLMANN – A guide on collecting samples using the CALEX device for patient self-testing.
An interview with Yvonne Schallberger, Bioanalytica, Lucerne, Switzerland Mrs. Schallberger decided to introduce the BÜHLMANN fPELA® turbo Test, that measures in random access as well as in batch mode the
Testimonial from Angela Suter and Dr. Cyril Fuhrer, Synlab Suisse SA, Lucerne, Switzerland You are successfully performing routine faecal calprotectin measurements with the BÜHLMANN fCAL® turbo Assay on the Beckman
A report from Dr. Marc-Antoine Bagnoud*, Dianalabs in Geneva, Switzerland Dianalabs is a mid-sized private lab founded in 1988 in Geneva, Switzerland, and part of the large swiss lab network
Jacqui McGuire and Neil Syme, Consultant Clinical Biochemists, Department of Biochemistry, Monklands Hospital NHS Lanarkshire, to the east of Glasgow, is the third largest NHS Health Board in Scotland. It
COVID has caused many changes in our day to day lives, with freedom and services intermittently restricted as the infection rates surge and abate. This pattern has also been evident
Bristol Zoo Gardens is a conservation and education charity founded by Henry Riley, a local physician and is the fifth oldest zoo in the world. It first opened its doors
Launched in summer 2020, the new BÜHLMANN fPELA turbidimetric immunoassay for faecal pancreatic elastase, complements the popular calprotectin fCAL turbo assay, that is widely used across the UK. Using the
Biochemical testing to support clinical decision making is essential, but certain analytes are still not routinely tested in-house. For these, patient samples are sent away to a referral laboratory for
The ongoing coronavirus pandemic means many patients with inflammatory bowel disease (IBD) are identified as high-risk and need to shield. Thus, any opportunities to prevent the need for them to
Dr. Jörg Oliver Thumfart, Labormedizinisches Zentrum Dr. Risch The Medical Laboratory Center Dr. Risch is a privately owned group of routine medical laboratories with 14 competence centres across Switzerland and
Weighing the sample is still considered the Gold-Standard sample extraction method for calprotectin. However, this is a time consuming and inconvenient method. Providing very high correlation to the weighing extraction
By Laura Bernstone, Principal Clinical Scientist, Clinical Biochemistry at County Durham and Darlington NHS Foundation Trust “Clinical Biochemistry at County Durham and Darlington NHS Foundation Trust is based on two
Accelerating Remote Patient Monitoring During the COVID-19 Pandemic Demands on healthcare resources continue to escalate as our aging population is living longer, often with more long-term health conditions. Changes to
A report from Dr. Jörg Oliver Thumfart*, Labormedizinisches Zentrum Dr. Risch “We successfully introduced the automated, turbidimetric assay for fecal calprotectin, the BÜHLMANN fCAL® turbo, on our Roche cobas® c501
In this humbling account, Rose Stanley, wife of long term Crohn’s sufferer Lee, shares her experiences of how, together, they tackle the daily challenges of living with the disease. It
The recent merger of clinical services across Basildon, Southend and Broomfield, now forms the Mid and South Essex University Hospital Trust with a catchment population of 1.5 million. The Gastroenterology
Pearl Avery – Poster presentation at ECCO 2020
Kathleen Sugrue – Poster presentation at ECCO 2020
As you may have seen from the NEQAS reports, the BÜHLMANN fCAL® turbo calprotectin assay is proving very popular, and its use has grown significantly over the last few years.
The Newcastle upon Tyne Hospitals Foundation Trust is one of the largest NHS trusts in the UK, covering six hospitals. Elodie and her team in the department of blood sciences
In this poster from ECCO 2019 Dr. Russell Walmsley describes his team’s study, that showed that the care for patient in a remote setting was not inferior to conventional care.
Faecal home tests are being used more frequently as part of the clinic routine. With several solutions from different manufacturers available there is a need to compare them in regard
Lee Stanley, long term Crohn’s sufferer shares his experience of managing his disease with the help of calprotectin self-testing. “Having Crohn’s disease for twenty-seven years has taught me many things;
The Benefits for Patients and Healthcare Staff of Routine IBDoc® Use The Mercy University Hospital in Cork is a designated Gastroenterology Centre of Excellence and has one of the largest
A Report of A. Suter* and Dr. C. Fuhrer** from SYNLAB *BMA HF/ Fachleiterin, **Head of Core Lab, FAMH Clinical Chemistry, NF hematology, microbiology and immunology; SYNLAB Suisse SA, Alpenquai
A Report of Martina Kobelt* and Karin Jung**, Zentrum für Labormedizin, KS St. Gallen, Switzerland *Senior Laboratory Technician Core Lab, **Deputy Head of Department Core Lab/FAMH Candidate Clinical Chemistry, Centre
Unilabs Portugal, a private European lab chain, made a comprehensive evaluation of different Calprotectin assays on the market. Finally, they choose the BÜHLMANN fCAL® turbo simply because it is faster,
Gastrointestinal/IBD Nurse of the Year 2018 introduces calprotectin home testing at her hospital. Pearl Avery of Dorset County Hospital NHS Trust has been awarded Gastrointestinal/IBD Nurse of the Year 2018 for her pioneering work
Follow the Evolution of Calprotectin Testing at James Cook University Hospital This interview with Mr Andrew Teggert, Clinical Scientist, James Cook University Hospital, Middlesbrough, discusses recent changes made to the faecal calprotectin testing
Pearl Avery from Dorset County Hospital shows very interesting data on the clinical validity and ease of use of the IBDoc® calprotectin home test at ECCO 2018.
Professor Russell Stothard and Dr Amaya Bustinduy Liverpool School of Tropical Medicine, London School of Hygiene and Tropical Medicine Our article highlights ongoing work in Uganda measuring morbidity associated with
At the European Crohn’s and Colitis Organisation, 13th Congress in Vienna in February 2018 Avery and Wilson of Dorset County Hospital Foundation Trust, Gastroenterology, Dorchester, UK presented the poster: IBDoc® Self-care/Point of care Calprotectin Test:
Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork In issue 2017-3 of Leading Edge, Mary O’Connell detailed her evaluation of the BÜHLMANN fCAL® turbo assay on the Abbott Architect C8000 analyser in comparison
Using IBDoc Faecal Calprotectin Testing Post Induction of anti-TNF Therapy G. Elsafi et al. Department of Gastroenterology, Mercy University Hospital, Cork At UEGW in Barcelona in October 2017 Dr. Elsafi and
Mary O’Connell née Deasy, Biochemistry Department, Mercy University Hospital, Cork, Ireland The Mercy University hospital is one of the largest users of the IBDoc test, with almost 500 patients using the system to
Mary O’Connell née Deasy, Biochemistry Department Mercy University Hospital Cork, Ireland describes her experience introducing the BÜHLMANN fCAL turbo assay onto her department’s Abbott Architect C8000. At the Biochemistry Department
Turbo Charged from the Start Rosie Forster and Karen Smith, Clinical Biochemistry, Queen Elizabeth Hospital Birmingham introduce Faecal Calprotectin testing into their laboratory using the BÜHLMANN fCAL® turbo assay. Faecal
In this video Caroline Bello from the University Hospital in Liege, Belgium presents the data of BÜHLMANN’s multicenter study with over 50 patients in Liege (Prof. Edouard Louis), Oslo (Dr.